Last reviewed · How we verify
NCT07521163: HBM-HPV
Effect of Health Belief Model-Based Education on Cervical Cancer Knowledge and HPV Vaccine Attitudes in Women
NA trial testing Health Belief Model-Based Education in Cervical Cancer in 100 participants. Not yet recruiting.
25 May 2026
Quick facts
| Lead sponsor | Muhammet Faruk Yigit |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 100 |
| Start date | 20 April 2026 |
| Primary completion | 25 May 2026 |
| Estimated completion | 30 June 2026 |
Drugs / interventions tested
- Health Belief Model-Based Education
Conditions studied
- Cervical Cancer — all drugs for Cervical Cancer →
- Human Papillomavirus Infection — all drugs for Human Papillomavirus Infection →
- Preventive Health Services — all drugs for Preventive Health Services →
Sponsor
Muhammet Faruk Yigit
Who can join
Adults 18 to 49, female only, with Cervical Cancer or Human Papillomavirus Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effect of a Health Belief Model-based educational intervention on women's knowledge of cervical cancer and their attitudes and beliefs toward HPV vaccination. The study will be conducted among women aged 18-49 years attending a primary health care center in Van, Turkey. Participants will be assigned to intervention and control groups. The intervention group will receive a structured, face-to-face educational program, while the control group will receive routine care. Data will be collected using validated questionnaires before and after the intervention. The findings are expected to contribute to improving preventive health behaviors and increasing HPV vaccination awareness among women.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07521163
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cervical Cancer
Currently open trials in the same condition.
- NCT07276360 — Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · Phase 2 · recruiting
- NCT05570422 — A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 · Phase 1 · recruiting
- NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
- NCT07209917 — Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India · NA · recruiting
- NCT07256236 — SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07521163 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Muhammet Faruk Yigit
- Last refreshed: 15 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07521163.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing